“Rochem International Inc. is very pleased to announce the successful FDA inspection of Amicogen (China) Biopharm Co Ltd in March of this year. This was the first FDA inspection of Amicogen and included the APIs Tulathromycin and the Ceftiofur series of products,...

Rochem International is delighted to have once again been a part of DCAT Week, held March 19-22, 2018 in Manhattan, NY.  After a year in hiatus, Rochem hosted their sushi lunch on the Wednesday afternoon, welcoming all who could stop in for some good food, drink and...

Rochem International is pleased to announce our continued Exclusive Strategic Partnership with Changzhou Sunlight Pharmaceutical Co., Ltd. (Sunlight). Rochem has been partners with Sunlight for nearly 20 years in the North American market and each has been highly...